Petros Pharmaceuticals to Present at the Benzinga Global Small Cap Conference
Petros Pharmaceuticals, a leader in men's health therapeutics, will be presenting at the Benzinga Global Small Cap Conference on December 8, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals, a leader in men's health therapeutics, will be presenting at the Benzinga Global Small Cap Conference on December 8, 2021. President and Chief Commercial Officer Fady Boctor is scheduled to deliver his presentation at 1:35 PM ET. Additionally, Mr. Boctor will be available for one-on-one meetings throughout the event, which runs from December 8 to 9. Petros focuses on addressing men's health issues, including erectile dysfunction and hormone health, by developing innovative therapeutic solutions.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was +10.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Dec. 2, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer Fady Boctor will present at the Benzinga Global Small Cap Conference, which is being held virtually from December 8 – 9, 2021.
Mr. Boctor will deliver his corporate presentation on Wednesday, December 8 at 1:35 PM ET.
Mr. Boctor will be available for one-on-one meetings throughout the conference.
Register for the conference:
https://www.benzinga.com/events/small-cap/december-2021-global/
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:https://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-present-at-the-benzinga-global-small-cap-conference-301436198.html
SOURCE Petros Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.